MARKET

REGN

REGN

Regeneron Pharmaceuticals
NASDAQ
623.43
+5.40
+0.87%
After Hours: 617.34 -6.09 -0.98% 19:52 06/24 EDT
OPEN
621.63
PREV CLOSE
618.03
HIGH
631.18
LOW
619.27
VOLUME
839.93K
TURNOVER
--
52 WEEK HIGH
818.90
52 WEEK LOW
504.84
MARKET CAP
65.36B
P/E (TTM)
15.20
1D
5D
1M
3M
1Y
5Y
1D
Regeneron Pharmaceuticals (REGN) Leans On Pipeline Promise As Undervaluation Case Stays In Focus
Simply Wall St · 21h ago
Biotech breakout: iShares Biotechnology ETF hits all-time high
Seeking Alpha · 1d ago
Regeneron myasthenia gravis therapy undergoes U.S. and EU review
Seeking Alpha · 1d ago
Viatris Soared 54%: Time To Be More Careful (Rating Downgrade)
Seeking Alpha · 1d ago
2 Underrated Weight Loss Stocks to Buy and Hold
The Motley Fool · 1d ago
The $11 Billion Reason Abbvie Stock Is Up Today
Barchart · 2d ago
Correction to AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash Article
The Wall Street Journal · 2d ago
AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion
The Wall Street Journal · 2d ago
More
About REGN
Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. The Company invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. The Company is accelerating drug development using its proprietary technologies, such as VelociSuite, which produces optimized fully human antibodies and new classes of bispecific antibodies. VelociSuite consists of VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, VelociHum, and other related technologies. Its marketed products include EYLEA (aflibercept); Dupixent (dupilumab); Libtayo (cemiplimab); Ordspono (odronextamab); Kevzara (sarilumab); Itepekimab; Lynozyfic, and others.

Webull offers Regeneron Pharmaceuticals Inc stock information, including NASDAQ: REGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, REGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading REGN stock methods without spending real money on the virtual paper trading platform.